NCT00000117View on ClinicalTrials.gov

Intravenous Immunoglobulin Therapy in Optic Neuritis

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

August 31, 1995

Study Completion Date

December 31, 1997

Conditions

Optic Neuritis

Interventions

DRUG

Immunoglobulin

Trial Locations (2)

Unknown

Mayo Clinic, Department of Neurology, Rochester

Mayo Clinic, Rochester

All Listed Sponsors

lead

National Eye Institute (NEI)

NIH

NCT00000117 - Intravenous Immunoglobulin Therapy in Optic Neuritis | Biotech Hunter | Biotech Hunter